MAP (mmHg) RCP (BPU/min)

Treatment

SHRNNa

SHRHNa

SHRNNa

SHRHNa

Phase 1 (saline)

136.4 ± 4.4

142.4 ± 4.5

216.0 ± 17.2

172.6 ± 20.6

Phase 2
(CEC 5µg/ kg)

121.0 ± 3.1

138.3 ± 3.2

201.8 ± 25.1

137.4 ± 12.4

Phase 3
(CEC 10µg /kg)

110.2 ± 2.3*

128.6 ± 6.1*

188.6 ± 20.6

158.6 ± 19.5

Table 2: MAP and RCP (BPU) in SHRNNa and SHRHNa rats in the absence and presence of low and high dose of CEC in renal vasoconstrictor experiment. Data are presented as mean SEM * p<0.05 vs. Phase1.
Goto home»